1. Home
  2. EDSA vs VEEE Comparison

EDSA vs VEEE Comparison

Compare EDSA & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • VEEE
  • Stock Information
  • Founded
  • EDSA 2015
  • VEEE 1994
  • Country
  • EDSA Canada
  • VEEE United States
  • Employees
  • EDSA N/A
  • VEEE N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • VEEE Marine Transportation
  • Sector
  • EDSA Health Care
  • VEEE Industrials
  • Exchange
  • EDSA Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • EDSA 6.2M
  • VEEE 6.4M
  • IPO Year
  • EDSA N/A
  • VEEE 2021
  • Fundamental
  • Price
  • EDSA $1.83
  • VEEE $2.46
  • Analyst Decision
  • EDSA Strong Buy
  • VEEE
  • Analyst Count
  • EDSA 1
  • VEEE 0
  • Target Price
  • EDSA $21.00
  • VEEE N/A
  • AVG Volume (30 Days)
  • EDSA 35.8K
  • VEEE 1.1M
  • Earning Date
  • EDSA 05-14-2025
  • VEEE 05-08-2025
  • Dividend Yield
  • EDSA N/A
  • VEEE N/A
  • EPS Growth
  • EDSA N/A
  • VEEE N/A
  • EPS
  • EDSA N/A
  • VEEE N/A
  • Revenue
  • EDSA N/A
  • VEEE $12,724,465.00
  • Revenue This Year
  • EDSA N/A
  • VEEE N/A
  • Revenue Next Year
  • EDSA N/A
  • VEEE N/A
  • P/E Ratio
  • EDSA N/A
  • VEEE N/A
  • Revenue Growth
  • EDSA N/A
  • VEEE N/A
  • 52 Week Low
  • EDSA $1.55
  • VEEE $2.05
  • 52 Week High
  • EDSA $5.59
  • VEEE $9.30
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 29.28
  • VEEE 48.05
  • Support Level
  • EDSA $1.88
  • VEEE $2.13
  • Resistance Level
  • EDSA $2.05
  • VEEE $2.35
  • Average True Range (ATR)
  • EDSA 0.08
  • VEEE 0.17
  • MACD
  • EDSA -0.00
  • VEEE 0.00
  • Stochastic Oscillator
  • EDSA 0.00
  • VEEE 44.59

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

Share on Social Networks: